MarketsSingle-source
2.1
Double Bond Pharma reports Q2 2026 operating loss of 0.6 million SEK
Dagens IndustriLO·SE·about 8 hours ago
Swedish research firm Irlab narrowed its operating loss to 16.7 million SEK in Q2 2026, compared to a 25.7 million SEK loss in the same period last year. The report reflects ongoing cash burn typical of early-stage research companies, though the year-over-year improvement suggests a reduction in operational expenditure.